Chemical Compound
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, [1S-(1a,3a,4ss)]-; BMS 200475; Baraclude; Entecavir; SQ 34676
CAS Registry Number
142217-69-4
Primary record
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, [1S-(1a,3a,4ss)]-; BMS 200475; Baraclude; Entecavir; SQ 34676
- 库存
- 6,710 克
- 纯度
- 98.5 %
- CAS
- 142217-69-4
化合物标识与属性
- CAS
- 142217-69-4
- PubChem CID
- 135398508
- SMILES
- C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N
- Canonical SMILES
- C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21
名称与同义词
- Entecavir
- Baraclude
- 142217-69-4
- anhydrous entecavir
- Entecavir anhydrous
- Entecavirum
- Entecavir hydrate
- Entecavir sodium
- entecavir (anhydrous)
- Entecavir (INN)
- Entecavir [INN]
- Entecavir Impurity
- entecavir monohydrate
- Entecavir [USAN:INN]
- RefChem:5792
- ENTECAVIR [MI]
- AC1L4BEC
- ENTECAVIR [HSDB]
- NNU2O4609D
- UNII-NNU2O4609D
- BMS 200475
- BMS-200475
- DTXSID4046446
- CHEMBL713
- ENTECAVIR [WHO-DD]
- (1R,3S,4S)-Entecavir
- CHEBI:473990
- MFCD00907887
- SCHEMBL28648
- DTXCID2026446
- Baraclude, BMS 200475
- HSDB 7334
- SCHEMBL367156
- C12H15N5O3
- orb1310954
- Entecavir, >=98% (HPLC)
- SCHEMBL15198001
- J05AF10
- QDGZDCVAUDNJFG-FXQIFTODSA-N
- GLXC-07996
- SQ 34676
- SQ-34676
- Entecavir, 98% - 25mg 25mg
- BMS-200475-01
- KS-00000G4U
- MSK10442
- ZINC3802690
- Tox21_112192
- ABP001043
- BDBM50248008
- CID153941
- EBC-26411
- MFCD11046562
- AKOS015854916
- AKOS015920226
- AKOS025312554
- C12-H15-N5-O3
- 5968Y6H45M
- AC-1593
- ACN-040790
- AN-1116
- CCG-267218
- CS-3160
- CS-T-21655
- DB00442
- GS-6386
- LS41110
- RL01752
- SQ34676
- BMS20047501
- NCGC00164563-01
- NCGC00164563-04
- NCGC00164563-06
- NCGC00164563-09
- NCGC00164563-11
- NCGC00164563-13
- AJ-45654
- BC677668
- BMS-20047501
- BR-77289
- HY-13623
- SC-20106
- SY028610
- AB0071164
- AB1004838
- J846.317D
- SQ 34,676
- AM20080880
- CAS-142217-69-4
- E0899
- S5246
- D07896
- J90027
- S-7388
- 1333204-94-6
- 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one
- 217E694
- A807868
- AR-270/43507901
- C107734
- EN300-37158607
- F093332
- Q418586
- 2-AMINO-9-((1S,3R,4S)-4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL)-1H-PURIN-6(9H)-ONE
- 209216-23-9
- 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one
- BRD-K08206212-001-01-2
- BRD-K08206212-002-01-0
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one
- 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-
- B0046-464095
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-3H-purin-6-one
- 2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one
- 9-[(1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]guanine
- ETV
- 2-amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one
- 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate
- 188399-46-4
- 2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-3,9-dihydro-6H-purin-6-one
- 2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl)-6,9-dihydro-3H-purin-6-one
- 2-Amino-9-[(1S)-2-methylene-3alpha-(hydroxymethyl)-4beta-hydroxycyclopentan-1alpha-yl]-1H-purin-6(9H)-one
- 2-Amino-9-[(1S,3R,4S)-2-methylene-3-(hydroxymethyl)-4-hydroxycyclopentan-1-yl]-1H-purin-6(9H)-one
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-1H-purin-6-one
- 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one hydrate (1:1)
- 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylene-cyclopentyl]-3,9-dihydro-purin-6-one
- 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one
- 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]
- 604-279-5
- 6H-Purin-6-One, 2-Amino-1,9-Dihydro-9-((1S,3R,4S)-4-Hydroxy-3-(Hydroxymethyl)-2-Methylenecyclopentyl)-Monohydrate
- 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, [1S-(1a,3a,4ss)]-; BMS 200475; Baraclude; Entecavir; SQ 34676
- 6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-